Ball or aerosol? Sin, soap and the pharmaceutical industry

Author:

Ratcliff Eric1

Affiliation:

1. Psychiatrist in private practice, Launceston, TAS, Australia

Abstract

Objective: The purpose of this paper is to provoke careful and continuing reconsideration of the relationship between psychiatrists and the pharmaceutical industry through historical analysis of trends in the promotion of psychotropic drugs. Conclusions: Psychiatrists remain concerned about the relationship of the profession with the pharmaceutical industry. From examination of my own extended experience of that relationship (including as a former Royal Australian and New Zealand College of Psychiatrists General Councilor and chair of the Clinical Practice Advisory and Ethical Practice Committees), attention is drawn to the influence of the industry on the categorization and naming of drugs, attempts to propose target disorders and the obsolescence of established agents. Caution in accepting the role of ‘opinion leader’ is recommended but it remains important for psychiatrists to continue to ethically engage with the industry.

Publisher

SAGE Publications

Subject

Psychiatry and Mental health

Reference8 articles.

1. Rubinstein WD, Rubinstein HL. Menders of the mind: a history of the Royal Australian and New Zealand College of Psychiatrists 1946–1996. Melbourne: Oxford University Press, 1996, p.26.

2. Drug Companies and CME: Prohibition, Declaration or Engagement?

3. Does Drug Promotion Adversely Influence Doctors' Abilities to Make the Best Decisions for Patients?

4. Views of Psychiatrists and Trainees on Drug Company Involvement in CME Activities

5. For example, advertisements courtesy of the Sir John Ramsay Memorial Library, Launceston General Hospital, Australia. (a) Miltown (meprobamate) as ‘An effective adjunct to psychotherapy.’ Am J Psychiatry 1965; 121(8): inside front cover; (b) Elavil HCL (amitriptyline HCl) is given a double-spread and the statement, ‘Extends the reach of psychotherapy.’ Am J Psychiatry 1965; 122 (3).

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3